High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
about
Consensus report of the 2015 Weinman International Conference on MesotheliomaCytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomasGender-Specific Molecular and Clinical Features Underlie Malignant Pleural MesotheliomaLoss of BAP1 Expression Occurs Frequently in Intrahepatic CholangiocarcinomaBRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasionLoss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytologyRecent insights emerging from malignant mesothelioma genome sequencingMithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma CellsMinimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesotheliomaAn asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutationGermline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interactionHigh-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesotheliomaLatest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesCombined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sComprehensive review of BAP1 tumor predisposition syndrome with report of two new casesBAP1 hereditary cancer predisposition syndrome: a case report and review of literatureFTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse modelPositive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesotheliomaModern management of malignant pleural mesotheliomaHMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.Mesothelioma: recent highlights.The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad.Novel systemic therapy against malignant pleural mesothelioma.Targeting the epigenome in malignant pleural mesotheliomaInhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition.Germline BAP1 mutations induce a Warburg effectBAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation.The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.Improving the Accuracy of Mesothelioma Diagnosis in China.BAP1 mutations in high-grade meningioma: implications for patient care.Malignant Mesothelioma: Time to Translate?Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma.Genes versus Environment: cytoplasmic BAP1 determines the toxic response to environmental stressors in mesothelioma.Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer.BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions.Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy.
P2860
Q27908468-BA4F735C-F5CA-4BA8-B002-9D50289D16BAQ28383444-3373805E-0C9E-4E7D-A07D-A708508C566BQ28384371-FB8AA0C8-1BC1-41BF-9990-FC03B70290BEQ28384496-1D99391D-7149-4A28-A44A-BB5DC4DD1DBCQ28387249-6B409724-252A-4312-8304-D669465E8273Q28387556-5B926B56-A5FE-40C9-AD7C-3EE27ACF5337Q28388301-ED926E23-53D6-4817-910F-A13BDCE12603Q28388640-B517AC67-1C16-40ED-8033-4268D6D07C9BQ28389071-602BF9F0-17A3-4909-8D10-115F15D58498Q28391365-2164BB17-0BC4-4C7E-B82C-022B3803BC4AQ28393257-9B0AE619-4471-4C48-8D00-3E30B9CF4D5BQ28395181-5BD760AD-4110-4600-9B63-296E8AC1E6FFQ28395597-E0B4C4F7-A6BF-49DA-BBA8-C7193C446959Q28396964-F9ED682D-2AAD-4078-BEDA-16E99A628CEFQ28397229-F05B51A8-9B4E-4DBA-82AC-69F6500F8F54Q28397624-EF941CAB-8D86-4A63-A685-197308B1B40FQ29248124-4573DCAE-32FE-4132-A776-10805F60DA52Q29248126-1C265F62-328B-4496-8576-CEDDB7B4F1FEQ29248127-AEADB435-CBEF-4329-B84B-8237CA639156Q33618428-8EDDC4B5-CC90-44C5-80BE-24CD8D86344DQ33871606-8F5C11B2-734E-4011-A0ED-80091DF185D5Q33871638-DE2D7436-2B86-4EF9-8F0C-446629CFF4CFQ33890499-D4315792-D2EE-4454-B0BC-8D4E026D4748Q33890546-AD04AF05-9D96-4257-8C5B-8A002757F6E3Q38429562-4D27A33F-FFCC-4AEC-B50A-C1B6F00FCA1EQ38653318-6487B7DB-A1E0-4D80-A6EF-5C9CF89D4962Q38700344-F04B243D-7B22-425A-ACE6-532EED98380AQ38725838-832CFE64-7EC7-43A6-9BE5-E2F6A9A2D7DCQ38950690-DDEAC4B2-48B5-4A35-B5C8-F97383FEABC0Q38972707-977EE8FB-0D81-48FE-BF3E-A045DCDE624CQ39051001-07466A30-1320-42D1-980C-E342A1A8D338Q39290955-D684BDAE-88BD-45AB-9A4D-7D98E5B8DC1CQ39366003-F2518DAF-63EE-44BF-A915-4293698E68B5Q40470064-819909A1-BCC6-4D74-BC39-9ABB1978E370Q41084421-43950099-495B-41E3-9FBF-7C7A3C34D6EDQ42728294-44AE899D-2C88-4DB8-AD5E-F6856C6A7737Q44246583-EA0B18AC-43EB-46C7-8D3E-E441DD8F0A6FQ46024349-9C09D507-8E5A-40BE-B9A8-75FE9042850BQ46129842-350A1480-769D-432A-BA8F-1F931826C5B6Q47329366-7D4B04FE-B65F-4D18-8465-1D2DBA6E65B4
P2860
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma
@nl
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@ast
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@en
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@en-gb
type
label
High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma
@nl
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@ast
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@en
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@en-gb
prefLabel
High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma
@nl
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@ast
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@en
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@en-gb
P2093
P2860
P50
P921
P3181
P1476
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
@en
P2093
Adi Gazdar
Amy Powers
Erin Flores
Haining Yang
Harvey I Pass
Maarit Tiirikainen
Masaki Nasu
Michael J Becich
Mika Tanji
P2860
P2880
P304
P3181
P356
10.1097/JTO.0000000000000471
P407
P577
2015-04-01T00:00:00Z